The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups.
This FOA also encourages the development of novel drug delivery systems in the pediatric
credit:
population.
Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field.
Applications submitted under this mechanism should be exploratory and novel.